RegionsNorth AmericaEuropeIsraelIndiaSoutheast AsiaEast AsiaLatin AmericaMiddle EastAfricaOceaniaGlobalUpdated 14 October 2026
AcquiredStartups
SearchExit tracker
Biggest in Foundation Medicine
Foundation Medicine → SAGA Diagnostics$595mAcquisition
Acquirer · Corporate

Foundation Medicine

1Exits tracked$595mDisclosed value$595mMedian price0Acquihires
Image: SAGA Diagnostics
Healthtech & bio · Research Triangle Park

Roche's Foundation Medicine agrees to buy SAGA Diagnostics for up to $595 million

The Lund University spin-out sells Pathlight, a blood test for leftover cancer that Medicare already covers for early-stage breast cancer. Its main 2021 funding round was about $12 million.

Price$595mRaised$17.6mLast stageStage n/aBuyer typeCorporate
Latest in Foundation MedicineMore stories here soon.
All Foundation Medicine exitsOpen tracker →
16 AprFoundation Medicine → SAGA DiagnosticsResearch Triangle Park · Stage n/a · raised $17.6m$595m$250m–1bn